INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 32 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,000 | -14.3% | 11,250 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $7,000 | -58.8% | 11,250 | 0.0% | 0.01% | -61.5% |
| Q1 2019 | $17,000 | +325.0% | 11,250 | 0.0% | 0.01% | +333.3% |
| Q4 2018 | $4,000 | +33.3% | 11,250 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $3,000 | -25.0% | 11,250 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $4,000 | – | 11,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 184,667 | $279,000 | 0.62% |
| IMS Capital Management | 29,536 | $35,000 | 0.03% |
| Paulson Wealth Management Inc. | 11,250 | $4,000 | 0.00% |
| Next Capital Management LLC | 1,139 | $2,000 | 0.00% |
| Renaissance Technologies | 362,282 | $547,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,972 | $39,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 181 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 103 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 40 | $0 | 0.00% |
| NORTHERN TRUST CORP | 15,074 | $23,000 | 0.00% |